BIOMAT Database Logo BIOMAT Database Logo

High serum immunoreactive trypsin not caused by cystic fibrosis. 1998

E F Moya, and J T Brocklebank, and J M Littlewood, and L M O'Connor, and M D Penney

UI MeSH Term Description Entries
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D008297 Male Males
D003550 Cystic Fibrosis An autosomal recessive genetic disease of the EXOCRINE GLANDS. It is caused by mutations in the gene encoding the CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR expressed in several organs including the LUNG, the PANCREAS, the BILIARY SYSTEM, and the SWEAT GLANDS. Cystic fibrosis is characterized by epithelial secretory dysfunction associated with ductal obstruction resulting in AIRWAY OBSTRUCTION; chronic RESPIRATORY INFECTIONS; PANCREATIC INSUFFICIENCY; maldigestion; salt depletion; and HEAT PROSTRATION. Mucoviscidosis,Cystic Fibrosis of Pancreas,Fibrocystic Disease of Pancreas,Pancreatic Cystic Fibrosis,Pulmonary Cystic Fibrosis,Cystic Fibrosis, Pancreatic,Cystic Fibrosis, Pulmonary,Fibrosis, Cystic,Pancreas Fibrocystic Disease,Pancreas Fibrocystic Diseases
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014357 Trypsin A serine endopeptidase that is formed from TRYPSINOGEN in the pancreas. It is converted into its active form by ENTEROPEPTIDASE in the small intestine. It catalyzes hydrolysis of the carboxyl group of either arginine or lysine. EC 3.4.21.4. Tripcellim,Trypure,beta-Trypsin,beta Trypsin
D018500 Diabetes Insipidus, Nephrogenic A genetic or acquired polyuric disorder characterized by persistent hypotonic urine and HYPOKALEMIA. This condition is due to renal tubular insensitivity to VASOPRESSIN and failure to reduce urine volume. It may be the result of mutations of genes encoding VASOPRESSIN RECEPTORS or AQUAPORIN-2; KIDNEY DISEASES; adverse drug effects; or complications from PREGNANCY. ADH-Resistant Diabetes Insipidus,Acquired Nephrogenic Diabetes Insipidus,Congenital Nephrogenic Diabetes Insipidus,Diabetes Insipidus Renalis,Diabetes Insipidus, Nephrogenic, Autosomal,Diabetes Insipidus, Nephrogenic, Type 1,Diabetes Insipidus, Nephrogenic, Type I,Diabetes Insipidus, Nephrogenic, Type II,Diabetes Insipidus, Nephrogenic, X-Linked,Nephrogenic Diabetes Insipidus,Nephrogenic Diabetes Insipidus, Type I,Nephrogenic Diabetes Insipidus, Type II,Vasopressin-Resistant Diabetes Insipidus

Related Publications

E F Moya, and J T Brocklebank, and J M Littlewood, and L M O'Connor, and M D Penney
Serum immunoreactive trypsin in cystic fibrosis.
January 1980, Scandinavian journal of gastroenterology. Supplement,
E F Moya, and J T Brocklebank, and J M Littlewood, and L M O'Connor, and M D Penney
Serum immunoreactive trypsin in cystic fibrosis.
January 1981, Thorax,
E F Moya, and J T Brocklebank, and J M Littlewood, and L M O'Connor, and M D Penney
Serum-immunoreactive-trypsin concentrations in cystic fibrosis.
May 1979, Lancet (London, England),
E F Moya, and J T Brocklebank, and J M Littlewood, and L M O'Connor, and M D Penney
Immunoreactive trypsin in cystic fibrosis.
January 1984, Journal of pediatric gastroenterology and nutrition,
E F Moya, and J T Brocklebank, and J M Littlewood, and L M O'Connor, and M D Penney
Serum immunoreactive trypsin and pancreatic lipase in cystic fibrosis.
July 1985, European journal of pediatrics,
E F Moya, and J T Brocklebank, and J M Littlewood, and L M O'Connor, and M D Penney
Immunoreactive trypsin screening for cystic fibrosis.
July 1982, Acta paediatrica Scandinavica,
E F Moya, and J T Brocklebank, and J M Littlewood, and L M O'Connor, and M D Penney
Plasma immunoreactive anionic pancreatic trypsin in cystic fibrosis.
January 1982, Journal of pediatric gastroenterology and nutrition,
E F Moya, and J T Brocklebank, and J M Littlewood, and L M O'Connor, and M D Penney
Trisomy 18, cystic fibrosis, and blood immunoreactive trypsin.
January 1984, Lancet (London, England),
E F Moya, and J T Brocklebank, and J M Littlewood, and L M O'Connor, and M D Penney
[High level of immunoreactive circulating trypsin in primary myocardiopathy in cystic fibrosis].
February 1982, Archives francaises de pediatrie,
E F Moya, and J T Brocklebank, and J M Littlewood, and L M O'Connor, and M D Penney
Immunoreactive trypsin and the prenatal diagnosis of cystic fibrosis.
May 1984, British journal of obstetrics and gynaecology,
Copied contents to your clipboard!